In summary, our study results demonstrate IL-24 disrupts the SDF-1/CXCR4 signaling pathway resulting in reduced cell migration and invasion and combination therapy of IL-24 with pharmacologic or genetic CXCR4 inhibitor produced a greater inhibitory activity on tumor cell migration. This evidence concerns the gene CXCL12 and neoplasm.